Stocksigma LogoStocksigma Logo

Vilin Bio Med Voluntarily Adopts Main Board Corporate Governance Reporting Standards

Vilin Bio Med Limited submitted its Integrated Corporate Governance Report for the quarter ended 30th Sep'26 on a voluntary basis

Vilin Bio Med Voluntarily Adopts Main Board Corporate Governance Reporting Standards

Vilin Bio Med Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 6:51 pm

Vilin Bio Med Voluntarily Adopts Main Board Corporate Governance Reporting Standards Vilin Bio Med Limited submitted its Integrated Corporate Governance Report for the quarter ended 30th Sep'26 on a voluntary basis. Although listed on NSE Emerge and exempt under Regulation 15(2)(b) of SEBI LODR Regulations, the company adopted Main Board governance norms. The board confirmed full compliance across committee compositions, reported zero investor grievances, and noted no cyber security breaches during the period. Additionally, the filing affirmed 100% holdings in unlisted entities Axia Pharma Private Limited and Vilo Speciality Pharma Private Limited.

Original exchange filing (PDF)

More announcements from Vilin Bio Med Ltd

All Vilin Bio Med Ltd announcements